At a glance
ClinicalIndex Comparison RecordN/ACompleted· 31 enrolled
Drug / intervention
Noradrenalinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Norepinephrine on Blood Volume Cardiac , Output and Systemic Filling Pressure in Patients Undergoing Liver Transplant .
In Brief
A clinical study evaluating Noradrenaline for Liver Transplantation. Completed, enrolled 31 participants across 1 site.
Detailed Summary
Early administration of NE in liver transplant recipient might enhance cardiac output through an increase in cardiac preload .
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Transplantation
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartDec 2019
First PostedMay 2020
Primary CompletionAug 2021
Study CompletionOct 2021
TodayJul 2026
First PostedMay 6, 2020
Enrollment StartDec 15, 2019
Primary CompletionAug 1, 2021
Study CompletionOct 1, 2021
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 6.2 years ago
Interventions
Noradrenalinedrug
Noradrenaline infusion for patients undergoing liver transplantaion from living donor .